Gastroenterology Flashcards
________ in saliva helps neutralize the acid in gastric reflux
bicarbonate
LES maintains tonic (sustained) contraction and relaxes through ___________ to allow the passage of food into the stomach
parasympathetic, vagal stimuli
The LES is a smooth muscle. What drugs could inhibit (or antagonize) the tonic contraction of this muscle?
Dihydropyridine CCBs
can cause relaxation of LES –> reflux of food
What do parietal cells do?
secreted HCl, which:
1) helps prevent microbial foodborne illnesses
2) activates certain enzymes
3) secretes IF –> allows body to absorb Vit B12
Antacids MOA
acid buffer, luminal side
Antacids pharmcokinetics
1) onset: immediate (< 5 min)
2) DOA: short (20-30 min) - limited to activity only while w/in stomach
**food can prolong DOA, potentially up to 3-hr
Which antacid is preferred?
they are generally interchangeable when doses appropriately
*just because a majority of OTC contain Calcium carbonates, does not make it a superior agent
What age group are OTC antacids indicated for?
> /= 12 y/o
calcium is approved for infants
What is/are the calcium carbonate antacid(s)?
Tums
Maalox (tabs)
Alka-Mints
What is/are the magnesium hydroxide antacid(s)?
Milk of Magnesia
What is/are the sodium bicarbonate antacid(s)?
Alka-Seltzer
original formula also contained 325mg aspirin
What is/are the bismuth subsalicylate antacid(s)?
Pepto-Bismol
What is/are the mixed antacid(s)?
Rolaids
Maalox (liquid)
Gaviscon
Mylanta
caution should be used when using antacids with medications that ______
can chelate
Calcium carbonate ADRs
- Ca++ may cause constipation/flatulence
- about 10% of Ca++ is absorbed into blood
Magnesium hydroxide ADRs
- Mg++ may cause diarrhea
- about 20% is absorbed into blood
Sodium bicarbonate ADRs
- forms NaCl
- may not be great for pt. on sodium-restrictive diets
Bismuth subsalicylate ADRs
- dark stools (an unnecessary pt. panic)
- tongue discoloration
- hearing loss
Aluminum hydroxide ADRs
some Al is absorbed and can accumulate –> altered mental statues (esp. in CKD)
**generally avoided
Natural product interactions of antacids
Lilly of the Valley and Strophanthus
*Both have major interactions w/ Ca++ and moderate interactions with aluminum hydroxide and bismuth subsalicylate
Which antacid can cause constipation?
calcium carbonate (Tums, Maalox tabs, Alka-Mints)
Which antacid can cause diarrhea?
magnesium hydroxide (milk of magnesia)
Histamine_2 Receptor Antagonists (H2RA) MOA
selective, competitive blockage of type 2 histamine receptors on basolateral side of parietal cells –> prevents stimulation of proton pump w/out blocking it directly
Histamine_2 Receptor Antagonists (H2RA) pharmacokinetics
1) onset: 30-45 min
2) DOA: 4-10 hr
Which Histamine_2 Receptor Antagonists (H2RA) is preferred?
products are considered interchangeable
What are the main Histamine_2 Receptor Antagonists (H2RA) drugs?
Famotidine (Pepcid)
Ranitidine (Zantac)
Cimetidine (Tagamet HB)
Nizatidine (Axid AR)
How long should pt. take antacids for?
= 2 wks OTC
therapy can be indefinite
How long should pt. take Histamine_2 Receptor Antagonists (H2RA) for?
< 2x/day for = 2 wks OTC
therapy can be indefinite under supervision
Histamine_2 Receptor Antagonists (H2RA) ADRs
- anti-androgenic (reversible gynecomastia, rarely impotence w/ cimetidine)
- arrhythmias (IV)
- HA
- dizziness
- GI disturbance
- tachyphylaxis (taking for more than a couple days can lead to tolerance and reduced effectiveness…should only taken prn)
Which Histamine_2 Receptor Antagonists (H2RA) is rarely used b/c it has lots of s/e and many drug interactions?
Cimetidine
**it is a CYP450 inhibitor
Histamine_2 Receptor Antagonists (H2RA) natural product interactions
- Caffeine (cimetidine)
- Hypericum (ranitidine and cimetidine
- many other moderate interactions
Dose of Histamine_2 Receptor Antagonists (H2RA) needs to be reduced in people with _________
renal disease
Proton Pump Inhibitors (PPI) MOA
selective, irreversible H/K/ATPase inhibition on luminal side of parietal cells
Proton Pump Inhibitors (PPI) pharmacokinetics
1) onset: 2-3 hr
2) DOA: 24 hr**
3) T1/2: 1 hr (except tenatoprazole is 8-9hr)
4) acid-labile medication so 50% decrease in bioavailability if taken with food (recommended to take qd 30 min before breakfast)
5) Takes up to 1-4 days for full effect of drug when initiating tx
6) Drugs become MORE bioavailable and absorption INCR. with repeat dosing
7) Metabolism: CYP2C19 and CYP3A4 (hepatic impairment and old age decr. clearance)
Proton Pump Inhibitors (PPI) drugs
Omeprazole (Prilosec) Esomeprazole (Nexium) Lansoprazole (Prevacid) Pantoprazole (Protonix) Rabeprazole (Aciphex)
How long should a patient take PPIs for?
< 1x/day for = 2 wks OTC
therapy can be indefinite and up to bid under supervision
Which PPI can be taken with food?
Dexlansoprazole
How long does it take for secretory activity to return after stopping PPIs?
3-5 days
Proton Pump Inhibitors (PPI) ADRs
- Mg++ depletion (monitor levels)
- osteoporosis (dietary Ca++ absorption requires acidic environment)
- Clostridium difficile infx
- community acquired pneumonia
- HA
- dizziness
- GI disturbance
Proton Pump Inhibitors (PPI) natural product interactions
- Grapefruit
- Hypericum
many other moderate interactions
Are PPIs or H2RAs better at immediate sx relief?
H2RAs
Which site of action do PPIs and H2RAs have in common?
Parietal cells
Lactose intolerance is very common in
Black (90%) and Asian (75%) populations
Lactose is a disaccharide composed of
glucose + galactose
Do probiotics help with lactose intolerance?
questionable
May improve bloating w/ lactase deficiency
Simethicone (Gas-X, Mylicon Infant’s drops) MOA
inert silicone polymer, “de-foaming” agent –> reduces surface tension of gas bubbles –> relieves gas
Simethicone pharmacokinetics
1) Not absorbed
Simethicone drug interactions
can bind to thyroid products (e.g. levothyroxine) and decr. absorption of thyroid med
Activated charcoal MOA
highly absorptive charcoal; possible adsorbent effects –> gas relief
**this product is charcoal plus w/ simethicone)
Activated charcoal pharmacokinetics
1) not absorbed
Activated charcoal drug interactions
may significantly impact absorption of medications
Alpha-Galactoside (Beano, Gaz away) MOA
mold-derived enzyme, cleaves oligosaccharides before reaching colonic bacteria
recommended for gas prevention with high-fiber diets
Alpha-Galactoside (Beano, Gaz away) cautions
avoid with DM and galactosemia
No known drug interactions
Pt. with flatulence would like OTC to relieve gas sx. Pt. has DM and would like to avoid a product that could interfere w/ absorption of medications. He has not food restrictions/intolerances. What drug should he try?
Simethicone
What is the recommended supplementation for lactose intolerance?
Lactaid (lactase enzyme)
**take at FIRST bite of lactose containing food
___________ laxatives are preferred if there is any concern for intestinal obstruction or if rapid onset is required
rectally administered
Senna (Senokot, Ex-Lax) classification
stimulant laxative
Senna (Senokot, Ex-Lax) MOA
anthraquinone –> direct action on intestinal mucosa or nerve plexus –> stimulates peristaltic activity
Senna (Senokot, Ex-Lax) pharmacokinetics
1) Onset: 6-24 hr
How long should pt. use Senna (Senokot, Ex-Lax) for?
less than 1 wk OTC
Senna (Senokot, Ex-Lax) ADRs
cramps, N/V, diarrhea, melanosis coli
**AVOID with actual/possible bowel obstruction
Senna (Senokot, Ex-Lax) natural products interactions
- Jalap (electrolyte/fluid depletion)
- Oleander (incr. risk of cardiac glycoside toxicity d/t K+ depletion
Bisacodyl (Dulcolax) class
Stimulant laxative
Bisacodyl (Dulcolax) MOA
directly irritates sm. mm. in intestine –> stimulates peristalsis
Bisacodyl (Dulcolax) pharmacokinetics
1) onset: 6-12 hr (oral); < 60 min suppository; < 20 min enema
2) minimal absorption (< 5%)
Bisacodyl (Dulcolax) ADRs
cramps, diarrhea, N/V, electrolyte disturbances, local irritation
**AVOID with actual/possible bowel obstruction
Bisacodyl (Dulcolax) natural product interactions
- Jalap (electrolyte/fluid depletion)
- Oleander (incr. risk of cardiac glycoside toxicity d/t K+ depletion
Polyethylene Glycol 3350 Electrolyte Sol’n (Miralax) class
osmotic (electrolyte) laxative
Polyethylene Glycol 3350 Electrolyte Sol’n (Miralax) MOA
osmotic water retention in stool and incr. stool frequency
**AVOID w/ actual/possible bowel obstruction
Polyethylene Glycol 3350 Electrolyte Sol’n (Miralax) pharmacokinetics
1) onset = 24-96 hr
2) minimal absorption
How long should a pt. use Bisacodyl (Dulcolax)?
< 1 week OTC
How long should a pt. use Polyethylene Glycol 3350 Electrolyte Sol’n (Miralax)?
< 1 week OTC
Polyethylene Glycol 3350 Electrolyte Sol’n (Miralax) ADRs
cramps, diarrhea, urticaria
Magnesium Citrate class
osmotic (electrolyte) laxatives
Magnesium Citrate MOA
osmotic retention of fluid in bowel
**AVOID with actual/potential bowel obstruction
Magnesium Citrate pharmacokinetics
1) onset = 30-60min
2) up to 30% absorbed
How long should pt. take Magnesium Citrate?
< 1 wk OTC
Magnesium Citrate ADRs
cramps, diarrhea, flatulence
magnesium toxicity early signs = hypotn, N/V, facial flushing, retention or urin, ileus, depression, lethargy
magnesium toxicity later signs = mm. weaknes, difficulty breathing, extreme hypotn, irregular heartbeat, cardiac arrest
**risk of magnesium toxicity incr. w/ renal failure
Magnesium Citrate natural product interactions
magnesium chelation and various moderate interactions
overall, osmotic lax are less likely to cz electrolyte abnormalities than stimulant lax
Docusate (Colace) class
bowel softener
Docusate (Colace) MOA
dioctyl dosium sulfosuccinate reduces surface tension of oil-water interface of the stool –> enhances incorporation of water and fat into stool
may also stimulate the secretion of water and electrolytes on contact w/ the mucosa
Docusate (Colace) pharmacokinetics
1) onset: 12-72 hr (oral); 2-15 min (rectal)
2) absorbed and excreted into bile
Docusate (Colace) ADRs
throat irritation (liquid formulation)
Docusate (Colace) natural product interactions
many moderate, may incr. absorption of various oral agents, including mineral oil (avoid combination)
theoretical concern that docusate salts can emulsify mineral oil, leading to systemic absorption and toxicity
A patient already taking senna could add which other agent(s) (with a different mechanism) for help with persistent constipation?
Docusate (Colace) - stool softener
mush and push
Psyllium (Metamucil) class
Bulk laxative
Psyllium (Metamucil) MOA
soluble fiber, absorbes water in the intestine –> viscous liquid –> promotes peristalsis AND reduces transit time
**AVOID if bowel is obstructed
Psyllium (Metamucil) pharmacokinetics
1) onset: 12-72 hrs
Psyllium (Metamucil) ADRs
cramps, respiratory distress (if inhaled in susceptible individuals), constipation (MUST incr. fluid intake as well)
may cause bowl obstruction
Psyllium (Metamucil) interactions
many moderate
can affect absorption (e.g. digoxin) d/t slowed GI transit
_________ are being used to reverse opioid induced constipation in the gut
opiate receptor antagonists
naloxone is esp. useful b/c it isn’t absorbed well so it stays in the gut and blocks opiate receptors there (relieving constipation) but it does not really get into the bloodstream so opiates can still act systemically
anti-diarrheal meds that are OTC rely on an ______________ mechanism, so there is abuse potential; especially with __________
opiate-based
loperamide
Loperimide (Immodium) class
opiate-like antidiarrheal
Loperimide (Immodium) MOA
decr. GI motility by effects on the circular and longitudinal mm.
reduced GI secretions produced by opiod receptor binding effects in the intestinal mucosa
Loperimide (Immodium) pharmacokinetics
1) onset: < 1 hr
2) poorly absorbed (when absorbed, metabolism via hepatic oxidative N-demethylation)
Loperimide (Immodium) ADRs
dizziness, cramps, nausea, toxic megacolon and rashes (rare), **pro-arrhythmic cz QTC prolongation (high doses and in combination)
**At high doses leads dependence and abuse
Loperimide (Immodium) natural product interactions
1) Henbane (additive anticholinergic effects)
2) Scopolia (additive anticholinergic effects)
3) Hypericum (induction of PgP)
Diphenoxylate and Atropine (Lomotil) class
opioid-like antidiarrheal
**This is a controlled substance
Diphenoxylate and Atropine (Lomotil) MOA
opiate receptor agonist (stimulates mu receptors) –> inhibits excessive GI motility and GI propulsion
Diphenoxylate and Atropine (Lomotil) pharmacokinetics
1) onset: 45-60min
2) extensively absorbed (hydrolyzed to active diphenoxylic acid)
OTC preparations of __________ contain a subtherapeutic amt of atropine to discourage abuse
Diphenoxylate and Atropine (Lomotil)
Diphenoxylate and Atropine (Lomotil) ADRs
many anti-cholinergic s/e d/t atropine (inhibited SLUD and dry skin) and CNS depressant effects
Diphenoxylate and Atropine (Lomotil) natural product interactions
1) Henbane (additive anticholinergic effects)
2) Scopolia (additive anticholinergic effects)
Lamotil and Imodium exert their anti-diarrheal effects based on what similar mechanism?
reducing GI motility (and also acting on opioid receptors)
What are the primary drug categories used to tx IBD?
1) Corticosteroids/Glucocorticoids
2) Aminosalicylates (5-ASA)
3) Immunosuppressants/Biologics
4) Antibiotics
Prednisone/prednisolone class
corticosteroid (includes both glucocorticoid and mineralcorticoid)
Prednisone/prednisolone MOA
1) modulates protein synthesis –> reduced migration of polymorphonuclear leukocytes and fibroblasts
2) reverses capillary permeability and lysosomal stabilization –> controls inflammation
3) immunosuppression
**use for IBD is limited to acute flares or salvage therapy
Prednisone/prednisolone pharmacokinetics
1) onset: days-weeks
2) DOA: 12-18 hr
Budesonide (Entocort EC) class
glucocorticoid
Budesonide (Entocort EC) MOA
synthesis –> reduced migration of polymorphonuclear leukocytes and fibroblasts
2) reverses capillary permeability andlysosomal stabilization –> controls inflammation
3) immunosuppression
4) **Release mechanism of enteric-coated tablets (Uceris) and capsules (Entocort) delay release until pH > 5.5
Budesonide (Entocort EC) pharmacokinetics
1) onset: days - weeks
2) absorption varies, overall minimal absorption (11%)
3) rapid and extensive first-pass (major CYP3A4)
4) Glucocorticoid»_space; mineralcorticoid receptor affinity (15-fold compared to prednisolone)
5) good topical activity w/ low systemic bioavailability
Budesonide (Entocort EC) natural product interactions
1) Grapefruit (CYP3A4 inhibitor)
2) Hypericum (CYP3A4 inducer)
Which corticosteroid(s) cover the duodenum/ jejunum?
1) Beclomethasone
2) Prednisone (PO/IV)
Which corticosteroid(s) cover the ileum?
1) Entocort EC
2) Budesonide
Which corticosteroid(s) cover the colon?
1) Budesonide
Which corticosteroid(s) cover the anus/rectum?
1) topical hydrocortisone
2) budesonide
Mesalamine class
aminosalicylates (5-ASA)
Mesalamine MOA
1) modulates local chemical mediators of inflammation (anti-inflammatory), esp. leukotrienes
2) free radical scavenger
3) inhibitor of TNF
Mesalamine pharmacokinetics
1) onset: 3-4 wks
2) absorption varies (baled on dosage form), overall minimal absorption (10%)
3) activity is mostly topical
Sulfasalazine class
aminosalicylates
Sulfasalazine MOA
1) **Prodrug of mesalamine (the Azo, N=N, bond is cleaved by colonic bacteria)
Sulfasalazine ADRs
1) dose dependent: nausea, anorexia, folate deficiency, HA, alopecia
2) dose independent: male infertility, rash, hemolytic anemia, hepatitis, pancreatitis, agranulocytosis
Sulfasalazine pharmacokinetics
1) onset: 3-4 wks
2) metabolism: intestinal bacteria –> sulfapyridine and 5-ASA –> 5-ASA is poorly absorbed and continues thru GI
3) absorption: sulfasalazine (< 15%); sulfapyridine (60%), 5-ASA (10%)
Sulfasalazine metabolism is dependent on
NAT (N-acetyltransferase) phenotype
- 5-ASA is metabolized in colonic mucosa by NAT1
- sulfapyridine is metabolized in liber by NAT 2
Which 5-ASA drug(s) cover the duodenum/jejunum?
1) Pentasa (ER caplet)
Which 5-ASA drug(s) cover the ileum?
1) Asacol (enteric coated tablet)
2) Claversal
3) Salofack
Which 5-ASA drug(s) cover the colon?
1) Sulfasalazine
2) Osalazine
Which 5-ASA drug(s) cover the anus/rectum?
1) topical 5-ASA
Which folic acid derivative immunosuppressant is MC used in Crohn’s and UC?
methotrexate
Which purine analog immunosuppressant is MC used in Crohn’s and UC?
6-mercaptopurine
Azathioprine class
purine analog antimetabolite (immunosuppressant)
Azathioprine MOA
inhibits purine synthesis and DNA replication –> anti-proliferative effect and apoptosis of T-cells
Azathioprine pharmacokinetics
1) onset: 1-3 mo.
2) absorption 60%
3) pro-drug (imidazolyl derivative) which is converted to active form 6-mercaptopurine
Azathioprine has a major interaction with
Ethanol (incr. risk for hepatotoxicities)
Tumor Necrosis Factor-alpha class
monoclonal Abs
immunosuppressant
Tumor Necrosis Factor-alpha MOA
inhibit TNFa
Tumor Necrosis Factor-alpha pharmacokinetics
1) onset: 1-2 wks
2) T1/2: 7-12 days
3) DOA: 8-48 wks
4) metabolisms: mononuclear phagocyte system
Tumor Necrosis Factor-alpha C/I
- active HepB
- MS, optic neuritis
- active serious infx
- chronic/recurrent infx
- current neoplasia
- Hx TB or positive PPD (untx)
- CHF (class III or IV)
Tumor Necrosis Factor-alpha ADRs
- infusion rxn/anaphylaxis
- infection (TB and HepB re-activation)
- HA
- transaminitis
- N/V
Premedication with __________ may be considered to prevent and manage infusion-related rxn to Tumor Necrosis Factor-alpha
antihistamines (H1-antag. +/- H2-antag.), acetaminophen, and/or corticosteroids
Infliximab (Remicade) class
anti-TNFa monoclonal Ab
(immunosuppressant)
xi = chimera (human-mouse) mab = monoclonal Ab
Infliximab (Remicade) MOA
chimeric IgGk that binds to both free and membrane bound TNFa
Infliximab (Remicade) major interaction
DMSO
Adalimumab (Humira) class
anti-TNFa
(immunosuppressant)
lim = immune/immunomodulator u = mouse mab = monoclonal antibody
Adalimumab (Humira) MOA
human mAb (IgGk) against TNFa
Drugs used for nausea/emesis
1) Serotonin (5-HT3) antagonists
2) Dopamine (D2) antagonists/prokinetics
3) Antipsychotics
4) Steroids
5) Cannabinoids
6) Antihistamines
Ondanstron class
Serotonin (5-HT3) antagonist
Ondanstron MOA
selectively antagonizes serotonin at 5-HT3-receptors (both peripherally on vagal n. terminals and centrally in chemoreceptor trigger zone)
Ondanstron pharmacokinetics
1) onset: 30 min
2) DOA: 3-6 hr (prolonged T1/2 w. hepatic impairment)
3) metabolism: 1’ hepatic - hydroxylation, glucuronide, sulfate conjugation, demethylation (involves CYP450 enzymes)
Ondanstron ADRs
- CV (QTc prolongation)
- HA
- fatigue/malaise
- diarrhea
- transient transaminitis
Ondanstron natural product interactions
1) Grapefruit (CYP3A4 inhibitor)
2) Hypericum (CYP3A4 inducer)
If serotonin antagonists prevent/treat nausea…what would you expect SSRIs to do?
s/e of nausea
Promethazine class
dopamine (D2) antagonist
Promethazine MOA
- blocks postsynaptic mesolimbic dopaminergic receptors in the brain
- exhibits a strong alpha-adrenergic blocking effect
- depresses release of hypothalamic and hypophyseal hormones
Promethazine pharmacokinetics
1) onset: 20 min (PO, IM) or 5 min (IV)
2) DOA: 4-6 hr
3) metabolism: significant first-pass, hydroxylation via CYP2D6 and N-demethylation via CYP2B6
Promethazine ADRs
- CV (arrhythmia, hypotension)
- dopamine suppression “extrapyramidal” effects (e.g. akathisia, acute dystonia, pseudoparkinsonism, tardive dyskinesia)
- endocrine (amenorrhea, gynecomastia, hyperglycemia)
Promethazine natural product interactions
1) Henbane (additive anticholinergic effects)
2) Scopolia (potentiate s/e and ADRs of anticholinergic drugs)
(anticholinergic = anti-SLUD)
Metoclopramide class
Dopamine (D2) antagonist
Metoclopramide MOA
- antagonizes dopamine receptors
- at high doses blocks serotonin receptors in chemoreceptor trigger zone of CNS (antiemetic)
Metoclopramide pharmacokinetics
1) onset: 30-60 min (PO), 10-15 min (IM), 1-3 min (IV)
2) DOA: 1-2 hr
3) metabolism: extensive absorption, N-demethylation and N-hydroxylation via CYP2D6 and CYP1A2
Metoclopramide ADRs
relatively few at low doses
at higher doses may see dopamine-suppression “extrapyramidal” effects (e.g. akathisia, acute dystonia, pseudoparkinsonism, tardive dyskinesia)
Metoclopramide has effects on which receptors?
both D2 receptors and 5-HT4 receptors